As neuroinflammatory processes such as microglial activation and cytokine generation are commonplace in multiple neurodegenerative diseases such as AD,22, 54 modulation of PS1/TREM2 trafficking may present alternative targeting strategies to treat AD. This evidence concerns the gene TREM2 and Alzheimer disease.